Citation Impact
Citing Papers
p53: puzzle and paradigm.
1996 Standout
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Histone Demethylase RBP2 Promotes Lung Tumorigenesis and Cancer Metastasis
2013
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid–binding lectin SIGLEC7 on the cell surface
2019
Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors
2010
Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer
2019
MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
2009
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Mdm2 promotes the rapid degradation of p53
1997 StandoutNature
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
2009
Biological functions of fucose in mammals
2017
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
p53 in growth control and neoplasia
1996
miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal
2016
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
C-type lectins in immunity and homeostasis
2018
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition
2016
Non-redundant functions of EMT transcription factors
2018
MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice
2017
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
2015
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
2016
MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion
2010
Calcium and mitochondria in the regulation of cell death
2015
miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 1 Subfamily A Member 2 and Family 2 Subfamily E Member 1 Expression
2017
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Metazoan MicroRNAs
2018 Standout
Epigenetic Modulation of miR-122 Facilitates Human Embryonic Stem Cell Self-Renewal and Hepatocellular Carcinoma Proliferation
2011
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
2013
Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion
2001
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
2009
miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression
2012
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
2011
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122
2015
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
2000 StandoutNatureNobel
UniCarbKB: New database features for integrating glycan structure abundance, compositional glycoproteomics data, and disease associations
2016
Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding
2013
Cancer-related inflammation: Common themes and therapeutic opportunities
2011
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Assessing the ceRNA Hypothesis with Quantitative Measurements of miRNA and Target Abundance
2014
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
MicroRNA control of epithelial–mesenchymal transition and metastasis
2012
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection
2019
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Development of micro RNA therapeutics is coming of age
2014
microRNA‐122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
2010
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Cancer Cell Cycles
1996 StandoutScience
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
2016
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
Mice carrying a human GLUD2 gene recapitulate aspects of human transcriptome and metabolome development
2016 StandoutNobel
One-Carbon Metabolism in Health and Disease
2016
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
1998 StandoutScience
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.
1999
Mesenchymal Stem Cell Targeting of Microscopic Tumors and Tumor Stroma Development Monitored by Noninvasive In vivo Positron Emission Tomography Imaging
2005
Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis
2014
MicroRNA‐122 regulates polyploidization in the murine liver
2016
Understanding the Chemistry and Biology of Glycosylation with Glycan Synthesis
2016
STAT3 and STAT5 Activation in Solid Cancers
2019
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
2000
Development of orally active inhibitors of protein and cellular fucosylation
2013
DEAD-box helicases: the Yin and Yang roles in viral infections
2018
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Asymmetric Catalysis via Cyclic, Aliphatic Oxocarbenium Ions
2017 StandoutNobel
p53 Status and the Efficacy of Cancer Therapy in Vivo
1994 Science
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Works of Michael Hsiao being referenced
The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer
2017
IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
2010
Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma
2017
H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM
2010
Glycine N-methyltransferase−/− mice develop chronic hepatitis and glycogen storage disease in the liver
2007
CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation
2012
CLEC5A is a critical receptor in innate immunity against Listeria infection
2017
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer
2009
hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing
2010
Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility
2013
Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells
2016
Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma
2008
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans
2011
MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma #
2008
Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma
2017
Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis
2013
Interactions of Carbon Monoxide and Metabotropic Glutamate Receptor Groups in the Nucleus Tractus Solitarii of Rats
2004
MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
2009
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
2012
Interaction of Carbon Monoxide and Adenosine in the Nucleus Tractus Solitarii of Rats
2003
Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase
1994
DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer
2015
Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer
2012
Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia
1994
Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers
2014
Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity
2016
Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase‐2 (COX‐2) expression and inhibited by a COX‐2–selective inhibitor, etodolac
2001
Silatecan DB-67 is a novel DNA topoisomerase I–targeted radiation sensitizer
2005
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
1994